Suppr超能文献

近期紫杉醇类纳米给药系统治疗癌症的临床进展。

Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer.

机构信息

Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Department of Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, the Netherlands.

出版信息

Int J Nanomedicine. 2020 Oct 22;15:8151-8166. doi: 10.2147/IJN.S272529. eCollection 2020.

Abstract

Conventional taxanes are used as cornerstone of the chemotherapeutical treatment for a variety of malignancies. Nevertheless, a large proportion of patients do not benefit from their treatment while they do suffer from severe adverse events related to the solvent or to the active compound. Cremophor EL and polysorbate 80 free formulations, conjugates, oral formulations and different types of drug delivery systems are some examples of the several attempts to improve the treatment with taxanes. In this review article, we discuss recent clinical developments of nanomediated drug delivery systems of taxanes for the treatment of cancer. Targeting mechanisms of drug delivery systems and characteristics of the most commonly used taxane-containing drug delivery systems in the clinical setting will be discussed in this review.

摘要

常规的紫杉烷类药物被用作多种恶性肿瘤化疗治疗的基石。然而,很大一部分患者并没有从治疗中受益,同时他们还遭受着与溶剂或活性化合物相关的严重不良反应。无聚氧乙烯蓖麻油 EL 和聚山梨醇酯 80 制剂、缀合物、口服制剂和不同类型的药物传递系统是几种试图改善紫杉烷类药物治疗的方法的例子。在这篇综述文章中,我们讨论了纳米介导的紫杉烷类药物传递系统治疗癌症的最新临床进展。本文将讨论药物传递系统的靶向机制和临床中最常用的含紫杉烷类药物传递系统的特点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c8/7592152/257b24504f92/IJN-15-8151-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验